Home | Welcome to Contract Pharma   
Last Updated Monday, January 26 2015

Print

Breaking News

January 22, 2013
Revenues up 8% in the quarter  Read More »
January 22, 2013
Flinois to lead technology division  Read More »
January 22, 2013
Aims to improve early clinical development  Read More »
Gil Roth
January 21, 2013
G-CON processing system will handle oral cholera vaccine  Read More »
Gil Roth
January 21, 2013
Biocatalysis expertise successfully transferred  Read More »
January 18, 2013
Burgess brings extensive industry and leadership experience  Read More »
January 18, 2013
Add Nordic countries  Read More »
January 18, 2013
Gains cancer therapeutics expertise  Read More »
January 18, 2013
Thommes to head infectious disease research growth  Read More »
January 17, 2013
Arnold to lead product development and technical services  Read More »
January 17, 2013
Expands manufacturing for monoclonal antibodies  Read More »
January 17, 2013
Will use Xtend technology for therapeutic antibody  Read More »
January 17, 2013
To develop delivery platform for cancer treatments  Read More »
January 17, 2013
Paladin granted rights to market APN311 in Canada and Africa  Read More »
January 16, 2013
Program aims to drive adoption of best practices  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On